Stiefel Laboratories

Stiefel Laboratories is a global pharmaceutical company specializing in dermatology. The company was founded in 1847 by John David Stiefel, Ferdinand von Hebra and Paul Unna, who were pioneers in dermatology. Stiefel Laboratories has a long history of innovation in skin care, being the first to introduce a number of treatments and products to the market.

History

Stiefel Laboratories was founded in 1847 in Germany. The company initially focused on soap production, but quickly expanded into other areas of dermatology. In the 20th century, Stiefel Laboratories was a pioneer in the development of corticosteroid creams and ointments, which are now widely used in the treatment of skin conditions.

In 2009, Stiefel Laboratories was acquired by GlaxoSmithKline, a British multinational pharmaceutical company. This acquisition allowed Stiefel to further expand its research and development capabilities and to reach a larger global market.

Products

Stiefel Laboratories produces a wide range of products for the treatment of skin conditions. These include topical steroid creams and ointments, acne treatments, antifungal medications, and moisturizers. The company is also involved in the development of new treatments for skin conditions, with a focus on innovation and research and development.

Research and Development

Research and development is a key focus for Stiefel Laboratories. The company is committed to developing new and innovative treatments for skin conditions. This includes both the development of new products and the improvement of existing ones. Stiefel's research and development efforts are supported by its parent company, GlaxoSmithKline.

See Also

• Pharmaceutical industry
• Dermatology
• GlaxoSmithKline

   This article is a pharmacology-related stub. You can help WikiMD by expanding it!

• Stiefel Laboratories Logo
  Stiefel Laboratories Logo
• 
  Stiefel, a GSK company headquarters